These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 31363742

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effects of cannabis abstinence on cognition and resting state network activity in people with multiple sclerosis: A preliminary study.
    Meza C, Stefan C, Staines WR, Feinstein A.
    Neuroimage Clin; 2024; 43():103622. PubMed ID: 38815510
    [Abstract] [Full Text] [Related]

  • 3. A preliminary investigation of sex differences in cognitive and fMRI changes following 28 days of cannabis abstinence.
    Meza C, Stefan C, Staines WR, Feinstein A.
    Mult Scler Relat Disord; 2024 Sep; 89():105759. PubMed ID: 39024968
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T2* mapping at 7 T MRI.
    Louapre C, Govindarajan ST, Giannì C, Madigan N, Nielsen AS, Sloane JA, Kinkel RP, Mainero C.
    Neuroimage Clin; 2016 Sep; 12():879-886. PubMed ID: 27872810
    [Abstract] [Full Text] [Related]

  • 6. Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis Patients.
    Conway DS, Planchon SM, Oh SH, Nakamura K, Thompson NR, Sakaie K, Ontaneda D.
    Mult Scler Relat Disord; 2021 Jan; 47():102635. PubMed ID: 33260053
    [Abstract] [Full Text] [Related]

  • 7. Effects of cannabis on cognition in patients with MS: a psychometric and MRI study.
    Pavisian B, MacIntosh BJ, Szilagyi G, Staines RW, O'Connor P, Feinstein A.
    Neurology; 2014 May 27; 82(21):1879-87. PubMed ID: 24789863
    [Abstract] [Full Text] [Related]

  • 8. Multiple sclerosis, cannabis, and cognition: A structural MRI study.
    Romero K, Pavisian B, Staines WR, Feinstein A.
    Neuroimage Clin; 2015 May 27; 8():140-7. PubMed ID: 26106538
    [Abstract] [Full Text] [Related]

  • 9. Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis.
    De Meo E, Portaccio E, Giorgio A, Ruano L, Goretti B, Niccolai C, Patti F, Chisari CG, Gallo P, Grossi P, Ghezzi A, Roscio M, Mattioli F, Stampatori C, Simone M, Viterbo RG, Bonacchi R, Rocca MA, De Stefano N, Filippi M, Amato MP.
    JAMA Neurol; 2021 Apr 01; 78(4):414-425. PubMed ID: 33393981
    [Abstract] [Full Text] [Related]

  • 10. Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach.
    Uher T, Vaneckova M, Sormani MP, Krasensky J, Sobisek L, Dusankova JB, Seidl Z, Havrdova E, Kalincik T, Benedict RH, Horakova D.
    Eur J Neurol; 2017 Feb 01; 24(2):292-301. PubMed ID: 27873386
    [Abstract] [Full Text] [Related]

  • 11. Impaired awareness: Why people with multiple sclerosis continue using cannabis despite evidence to the contrary.
    Feinstein A, Meza C, Stefan C, Staines WR.
    Brain Behav; 2021 Aug 01; 11(8):e2220. PubMed ID: 34087949
    [Abstract] [Full Text] [Related]

  • 12. Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence.
    Hanson KL, Winward JL, Schweinsburg AD, Medina KL, Brown SA, Tapert SF.
    Addict Behav; 2010 Nov 01; 35(11):970-6. PubMed ID: 20621421
    [Abstract] [Full Text] [Related]

  • 13. Early Cannabis Use and Neurocognitive Risk: A Prospective Functional Neuroimaging Study.
    Tervo-Clemmens B, Simmonds D, Calabro FJ, Montez DF, Lekht JA, Day NL, Richardson GA, Luna B.
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Aug 01; 3(8):713-725. PubMed ID: 30033100
    [Abstract] [Full Text] [Related]

  • 14. Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study.
    Hegedüs K, Kárpáti J, Iljicsov A, Simó M.
    Mult Scler Relat Disord; 2019 Oct 01; 35():150-155. PubMed ID: 31376686
    [Abstract] [Full Text] [Related]

  • 15. Multiple sclerosis and cannabis: a cognitive and psychiatric study.
    Ghaffar O, Feinstein A.
    Neurology; 2008 Jul 15; 71(3):164-9. PubMed ID: 18272863
    [Abstract] [Full Text] [Related]

  • 16. Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues.
    Benedict RHB, Amato MP, DeLuca J, Geurts JJG.
    Lancet Neurol; 2020 Oct 15; 19(10):860-871. PubMed ID: 32949546
    [Abstract] [Full Text] [Related]

  • 17. Isolated cognitive impairment in people with multiple sclerosis: frequency, MRI patterns and its development over time.
    Bouman PM, van Dam MA, Jonkman LE, Steenwijk MD, Schoonheim MM, Geurts JJG, Hulst HE.
    J Neurol; 2024 May 15; 271(5):2159-2168. PubMed ID: 38286843
    [Abstract] [Full Text] [Related]

  • 18. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis.
    Hohol MJ, Guttmann CR, Orav J, Mackin GA, Kikinis R, Khoury SJ, Jolesz FA, Weiner HL.
    Arch Neurol; 1997 Aug 15; 54(8):1018-25. PubMed ID: 9267977
    [Abstract] [Full Text] [Related]

  • 19. Brief international cognitive assessment for MS (BICAMS) and global brain volumes in early stages of MS - A longitudinal correlation study.
    Skorve E, Lundervold AJ, Torkildsen Ø, Riemer F, Grüner R, Myhr KM.
    Mult Scler Relat Disord; 2023 Jan 15; 69():104398. PubMed ID: 36462469
    [Abstract] [Full Text] [Related]

  • 20. Lesion accumulation is predictive of long-term cognitive decline in multiple sclerosis.
    Ouellette R, Bergendal Å, Shams S, Martola J, Mainero C, Kristoffersen Wiberg M, Fredrikson S, Granberg T.
    Mult Scler Relat Disord; 2018 Apr 15; 21():110-116. PubMed ID: 29550717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.